NCT03248934

Brief Summary

The primary objective of this study is evaluate the diagnostic accuracy of a patient self-administered clinical examination of the hip compared with a traditional clinical examination (i.e. index test).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 18, 2017

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

August 10, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 15, 2017

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 13, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 13, 2018

Completed
Last Updated

December 17, 2019

Status Verified

May 1, 2019

Enrollment Period

8 months

First QC Date

August 10, 2017

Last Update Submit

December 16, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sensitivity

    As measured by a questionnaire evaluating the diagnostic test's ability to identify a positive finding when the targeted diagnosis is actually present (i.e. true positive).

    End of clinician examination, 20 minutes

Secondary Outcomes (4)

  • Specificity

    End of clinician examination, 20 minutes

  • Diagnostic accuracy measure of positive likelihood ratio

    End of clinician examination, 20 minutes

  • Diagnostic accuracy measure of negative likelihood ratio

    End of clinician examination, 20 minutes

  • Diagnostic accuracy measure of post-test probabilities

    End of clinician examination, 20 minutes

Study Arms (2)

Patient Self-Administered Exam Group

EXPERIMENTAL

Participants with hip pain presenting in the hip preservation clinics will be asked to complete two diagnostic exams. Participants with hip pain will first complete a patient self-administered diagnostic exam.

Other: Patient Self-Administered Diagnostic Exam

Clinician-Performed Exam Group

ACTIVE COMPARATOR

Participants with hip pain presenting in the hip preservation clinics will be asked to complete two diagnostic exams. Participants with hip pain will next complete a clinician-performed diagnostic exam.

Other: Clinician-Performed Diagnostic Exam

Interventions

Participants will complete a patient self-administered diagnostic exam. A physician will be available to monitor the patient and record findings but will not physically assist the participants.

Patient Self-Administered Exam Group

A clinician-performed diagnostic exam will be completed on the patients.

Clinician-Performed Exam Group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: 18-80 years
  • Seeking care for hip related pain and/or clicking, catching, giving way or stiffness
  • Able to sign or verbalize study consent
  • No other medical conditions (e.g. gynecological or urinary pathology) that may affect study results
  • English speaking

You may not qualify if:

  • Patients with primary lumbar spine, sacro-iliac or other non-hip related pain as determined with clinical examination
  • Previous hip surgery
  • Previous hip injury that would normally exclude from examination as standard practice
  • Unable to sign or verbalize consent
  • Other non-musculoskeletal pathology that may affect study results (e.g. gynecological or urinary pathology)
  • Non-English speaking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Health System

Durham, North Carolina, 27710, United States

Location

Study Officials

  • Richard C. Mather

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 10, 2017

First Posted

August 15, 2017

Study Start

July 18, 2017

Primary Completion

March 13, 2018

Study Completion

March 13, 2018

Last Updated

December 17, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations